David Coman

Insider Reports History

Entity
Individual
Location
C/O Lifesci Acquisition II Corp., 250 W 55 Th Street, #3401, New York, New York
Signature
/s/ Christine Pellizzari, Attorney-in-fact for David Coman
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David Coman:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Science 37 Holdings, Inc. Chief Executive Officer, Former Director Common Stock 0 $0 $5.75 Mar 12, 2024 Direct
Science 37 Holdings, Inc. Chief Executive Officer, Former Director Restricted Stock Units 0 $0 $5.75 Mar 12, 2024 Direct
Science 37 Holdings, Inc. Chief Executive Officer, Former Director Earn-Out Right 0 Mar 12, 2024 Direct
Science 37 Holdings, Inc. Chief Executive Officer, Former Director Stock Option 0 Mar 12, 2024 Direct

Insider Reports Filed by David Coman

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SNCE Science 37 Holdings, Inc. Mar 12, 2024 5 -486,536 4 Mar 12, 2024 Chief Executive Officer, Former Director
SNCE Science 37 Holdings, Inc. Aug 12, 2023 3 -63,613 4 Aug 15, 2023 Chief Executive Officer
SNCE Science 37 Holdings, Inc. Apr 28, 2023 3 0 4 May 2, 2023 Chief Executive Officer
SNCE Science 37 Holdings, Inc. Aug 12, 2022 1 0 4 Aug 16, 2022 Chief Executive Officer
SNCE Science 37 Holdings, Inc. Jan 7, 2022 1 0 4 Jan 11, 2022 Chief Executive Officer
SNCE Science 37 Holdings, Inc. Oct 6, 2021 2 0 4/A Oct 12, 2021 Chief Executive Officer, Director
SNCE Science 37 Holdings, Inc. Oct 6, 2021 0 0 3 Oct 8, 2021 Chief Executive Officer, Director